Skip to main content
SpringerLink
Log in

Esophagectomy for High Grade Dysplasia is Safe, Curative, and Results in Good Alimentary Outcome

  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

The increasing adoption of endoscopic therapies and expectant surveillance for patients with high grade dysplasia (HGD) in Barrett’s esophagus has created considerable controversy regarding the ideal treatment choice. Confusion may be due, in part, to a limited understanding of the outcomes associated with surgical resection for HGD and extrapolation of data derived from patients undergoing an esophagectomy for invasive cancer. The purpose of our study was to document the perioperative and symptomatic outcomes and long-term survival after esophagectomy for HGD of the esophagus.

Material and Methods

The study population consisted of 38 patients who underwent esophagectomy for biopsy-proven HGD between 10/1999 and 6/2005. Three patients were excluded from analysis due to obvious tumor on upper endoscopy. Patients were evaluated regarding ten different foregut symptoms and administered a ten-question appraisal of eating and bowel habits. Outcome measures included postoperative morbidity and mortality, the prevalence of invasive cancer in the esophagectomy specimens, symptomatic and functional alimentary results, patient satisfaction, and long-term survival. Median follow-up was 32 months (range, 7–83).

Results

Thirty-day postoperative and in-hospital mortality was zero. Complications occurred in 37% (13/35), and median length of stay was 10 days. Occult adenocarcinoma was found in 29% (10/35) of surgical specimens (intramucosal in four; submucosal in five; and intramuscular in one with a single positive lymph node.) Patients consumed a median of three meals per day, most (76%, 26/34) had no dietary restrictions, and two-thirds (23/34) considered their eating pattern to be normal or only mildly impacted. Meal size, however, was reported to be smaller in the majority (79%, 27/34) of patients. Median body mass index (BMI) decreased slightly after surgery (28.6 vs 26.6, p > 0.05), but no patient’s BMI went below normal. The number of bowel movements/day was unchanged or less in a majority (82%) of patients after surgery. Fifteen of 34 (44%) patients reported loose bowel movements, which occurred less often than once per week in 10 of the 15. One patient had symptoms of dumping. Mean symptom severity scores improved for all symptoms except dysphagia and choking. Four patients developed foregut symptoms that occurred daily. Most patients (82%) required at least one postoperative dilation for dysphagia. Almost all (97%) patients were satisfied. Disease-free survival was 100%, and overall survival was 97% (34/35) at a median of 32 months.

Conclusion

Esophagectomy is an effective and curative treatment for HGD and can be performed with no mortality, acceptable morbidity, and good alimentary outcome. These data provide a gold standard for comparison to alternative therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Pohl H, Welch HG. J Natl Cancer Inst. 2005;97:142–146.

    Article  PubMed  Google Scholar 

  2. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society, 2007. http://www.cancer.org Last accessed March 31, 2007.

  3. Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology. 1989;96:1249–1256.

    PubMed  CAS  Google Scholar 

  4. Spechler SJ. The natural history of dysplasia and cancer in esophagitis and Barrett esophagus. J Clin Gastroenterol. 2003;36(5 Suppl):S2–S5. (discussion S26–S28).

    Article  PubMed  Google Scholar 

  5. Ormsby AH, Petras RE, Henricks WH, Rice TW, Rybicki LA, Richter JE, Goldblum JR. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut. 2002;51:671–676.

    Article  PubMed  CAS  Google Scholar 

  6. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol.. 2001;32(4):368–378.

    Article  PubMed  CAS  Google Scholar 

  7. Skinner DB, Walther BC, Riddell RH, et al. Barrett’s esophagus: Comparison of benign and malignant cases. Ann Surg. 1983;198:554–566.

    Article  PubMed  CAS  Google Scholar 

  8. Schmidt HG, Riddell RD, Walther B, et al. Dysplasia in Barrett’s esophagus. J Cancer Res Clin Oncol. 1985;110:145–152.

    Article  PubMed  CAS  Google Scholar 

  9. Lee RG. Dysplasia in Barrett’s esophagus: A clinicopathologic study of six patients. Am J Surg Pathol. 1985. 845–852.

  10. Hamilton SR, Smith RL. The relationship between columnar epithelial dysplasia and invasive carcinoma arising in Barrett’s esophagus. Am J Clin Pathol. 1987;87:301–312.

    PubMed  CAS  Google Scholar 

  11. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett’s esophagus without grossly recognizable neoplastic lesions. Gastroenterology. 1998;94:81–90.

    Google Scholar 

  12. DeMeester TR, Attwood SE, Smyrk TC, Therkildsen DH, Hinder RA. Surgical therapy in Barrett’s esophagus. Ann Surg. 1990;212(4):528–540.

    Article  PubMed  CAS  Google Scholar 

  13. Altorki NK, Sunagaawa M, Little AG, et al. High-grade dysplasia in the columnar-lined esophagus. Am J Surg. 1991;161:97–100.

    Article  PubMed  CAS  Google Scholar 

  14. McArdle JE, Lewin KJ, Randall G, et al. Distribution of dysplasia and early invasive carcinoma in Barrett’s esophagus. Hum Pathol. 1992;23:479–482.

    Article  PubMed  CAS  Google Scholar 

  15. Pera M, Trastek VF, Carpenter HA, et al. Barrett’s esophagus with high-grade dysplasia: An indication for esophagectomy. Ann Thorac Surg. 1999;54:204.

    Google Scholar 

  16. Levine DS, Haggett RC, Blout PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology. 1993;105:40–50.

    PubMed  CAS  Google Scholar 

  17. Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett’s esophagus: does it help? J Thorac Cardiovasc Surg. 1993;105(3):383–388.

    PubMed  Google Scholar 

  18. Ortiz A, Martinez de Haro LF, Parrilla P, et al. Conservative treatment versus antireflux surgery in Barrett’s esophagus: Long-term results of a prospective study. Br J Surg. 1996;83:274–227.

    Article  PubMed  CAS  Google Scholar 

  19. Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg. 1994;108(5):813–822.

    PubMed  CAS  Google Scholar 

  20. Edwards MJ, Gable DR, Lentsch AB, et al. The rationale for esophagectomy as the optimal therapy for Barrett’s esophagus with high-grade dysplasia. Ann Surg. 1996;223:585–591.

    Article  PubMed  CAS  Google Scholar 

  21. Ferguson MK, Naunheim KS. Resection for Barrett’s mucosa with high-grade dysplasia: Implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997;114:824–829.

    Article  PubMed  CAS  Google Scholar 

  22. Cameron AJ, Carpenter HA. Barrett’s esophagus, high-grade dysplasia, and early adenocarcinoma: A pathological study. Am J Gastroenterol. 1997;92:586–591.

    PubMed  CAS  Google Scholar 

  23. Patti MG, Arcerito M, Feo CV, Worth S, De Pinto M, Gibbs VC, Gantert VC, Tyrrell D, Ferrell LF, Way LW. Barrett’s esophagus: a surgical disease. J Gastrointest Surg. 1999;3(4):397–403.

    Article  PubMed  CAS  Google Scholar 

  24. Nigro JJ, Hagen JA, DeMeester TR, et al. Occult esophageal adenocarcinoma: Extent of disease and implications for effective therapy. Ann Surg. 1990;230:433–444.

    Article  Google Scholar 

  25. Nguyen NT, Schauer P, Luketich JD. Minimally invasive esophagectomy for Barrett’s esophagus with high-grade dysplasia. Surgery. 2000;127:284–290.

    Article  PubMed  CAS  Google Scholar 

  26. Zaninotto G, Parenti AR, Ruol A, et al. Oesophageal resection for high-grade dysplasia in Barrett’s oesophagus. Br J Surg. 2000;87:1102–1105.

    Article  PubMed  CAS  Google Scholar 

  27. Headrick JR, Nichols FC, Miller DL, Allen MS, Trastek VF, Deschamps C, Schleck CD, Thompson AM, Pairolero PC. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg. 2002;73(6):1697–1703.

    Article  PubMed  Google Scholar 

  28. Romagnoli R, Collard JM, Gutschow C, Yamusah N, Salizzoni M. Outcomes of dysplasia arising in Barrett’s esophagus: a dynamic view. J Am Coll Surg. 2003;197:365–371.

    Article  PubMed  Google Scholar 

  29. Tseng EE, Wu TT, Yeo CJ, Heitmiller RF. Barrett’s esophagus with high grade dysplasia: surgical results and long-term outcome - an update. J Gastrointest Surg. 2003;7(2):164–170.

    Article  PubMed  Google Scholar 

  30. Reed MF, Tolis G, Edil BH, Allan JS, Donahue DM, Gaissert HA, Moncure AC, Wain JC, Wright CD, Mathisen DJ. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg. 2005;79:1110–1115.

    Article  PubMed  Google Scholar 

  31. Sujendran V, Sica G, Warren B, Maynard N. Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett’s oesophagus. Eur J Cardiothorac Surg. 2005;28:763–766.

    Article  PubMed  Google Scholar 

  32. Moraca RJ, Low DE. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg. 2006;141:545–551.

    Article  PubMed  Google Scholar 

  33. Rice TW. Esophagectomy is the treatment of choice for high-grade dysplasia in Barrett’s esophagus. Am J Gastroenterol. 2006;101:2177–2184.

    Article  PubMed  Google Scholar 

  34. Chang LC, Oelschlager BK, Quiroga E, Parra JD, Mulligan M, Wood DE, Pellegrini CA. Long-term outcome for high-grade dysplasia or cancer found during surveillance for Barrett’s esophagus. J Gastrointest Surg. 2006;10:341–346.

    Article  PubMed  Google Scholar 

  35. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg. 1980;67:381–390.

    Article  PubMed  CAS  Google Scholar 

  36. Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg. 2003;75:217–222.

    Article  PubMed  Google Scholar 

  37. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Eng J Med. 2002;346(15):1128–1137.

    Article  Google Scholar 

  38. Swanson SJ, Batirel HF, Bueno R, Jaklitsch MT, Lukanich JM, Allred E, Mentzer SJ, Sugarbaker DJ. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg. 2001;72:1918–1925.

    Article  PubMed  CAS  Google Scholar 

  39. Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236(2):177–183.

    Article  PubMed  Google Scholar 

  40. Portale G, Hagen JA, Peters JH, Chan LS, DeMeester SR, Gandamihardja TA, DeMeeser TR. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006;202(4):588–596.

    Article  PubMed  Google Scholar 

  41. Hulscher JBF, van Sandick JW, de Boer AGEM, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;3477:1662–1669.

    Article  Google Scholar 

  42. Schnell TG, Sontag SL, Chejfec G, et al. Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia. Gastroenterology. 2001;120(7):1607–1619.

    Article  PubMed  CAS  Google Scholar 

  43. Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett’s esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004;99(9):1657–1666.

    Article  PubMed  Google Scholar 

  44. Oh DS, Hagen JA, Chandrasoma PT, et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg. 2006;203:152–161.

    Article  PubMed  Google Scholar 

  45. Buttar NS, Wang KK, Sebo TJ, et al. Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology. 2001;120(7):1630–1639.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Thoracic and Foregut Surgery, Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

    Valerie A. Williams, Thomas J. Watson, Fernando A. Herbella, Oliver Gellersen, Daniel Raymond, Carolyn Jones & Jeffrey H. Peters

  2. Division of Thoracic and Foregut Surgery, Department of Surgery, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA

    Valerie A. Williams & Thomas J. Watson

Authors
  1. Valerie A. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas J. Watson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fernando A. Herbella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oliver Gellersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel Raymond
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carolyn Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jeffrey H. Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas J. Watson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, V.A., Watson, T.J., Herbella, F.A. et al. Esophagectomy for High Grade Dysplasia is Safe, Curative, and Results in Good Alimentary Outcome. J Gastrointest Surg 11, 1589–1597 (2007). https://doi.org/10.1007/s11605-007-0330-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-007-0330-9

Keywords

Search

Navigation